During cardiogenesis, a subset of epicardial cells undergoes epithelial-mesenchymal-transition (EMT) and the resulting epicardial-derived cells (EPDCs) contribute to the formation of coronary vessels. Our previous data showed hypoxia inducible factor-1a (HIF-1a) expression at specific sites within the epicardium and support a link between hypoxia inducible factors (HIFs) and the patterning of coronary vasculogenesis. To better understand the autocrine role of HIFs in the epicardium, we transduced adenovirus mediated expression of constitutively active HIF-1a (AdcaHIF1a) into the embryonic avian epicardium where the vascular precursors reside. We found that introducing caHIF1a into the epicardial mesothelium prevented EPDCs from proper migration into the myocardium. In vitro collagen gel assays and ex vivo organ culture data further confirmed that infection with AdcaHIF1a impaired the ability of EPDCs to invade. However, the proficiency of epicardial cells to undergo EMT was enhanced while the movement of EPDCs within the sub-epicardium and their differentiation into smooth muscle cells were not disrupted by caHIF1a. We also showed that the transcript level of Flt-1 (VEGFR1), which can act as a VEGF signaling inhibitor, increased several fold after introducing caHIF1a into epicardial cells. Blocking the activation of the VEGF pathway in epicardial cells recapitulated the inhibition of EPDC invasion. These results suggest that caHIF1a mediated up-regulation of Flt-1, which blocks the activation of the VEGF pathway, is responsible for the inhibition of EPDC myocardial migration. In conclusion, our studies demonstrate that HIF signaling potentially regulates the degree of epicardial EMT and the extent of EPDC migration into the myocardium, both of which are likely critical in patterning the coronary vasculature during early cardiac vasculogenesis. These signals could explain why the larger coronaries appear and remain on the epicardial surface.
Introduction
The epicardium is the last cardiac layer to emerge, arising from the pro-epicardial serosa to form the outermost layer of the heart. This tissue plays crucial roles during embryonic heart development, especially in coronary vasculogenesis (Hiruma and Hirakow, 1989; Mikawa and Fischman, 1992; Poelmann et al., 1993; Viragh and Challice, 1981; Winter and Gittenberger-de Groot, 2007) . Concurrent with the formation of the epicardium, a subset of epicardial cells undergoes epithelial-mesenchymal transformation (EMT) and starts migration into the sub-epicardial matrix. Some of these epicardial-derived cells (EPDCs) remain within the sub-epicardium whereas a subpopulation migrates farther into the compact zone of the myocardium. EPDCs have the ability to differentiate and give rise to a variety of cell types, including cellular elements of the coronary vasculature (Mikawa and Fischman, 1992; Olivey et al., 2004; Poelmann et al., 1993; Wessels and Perez-Pomares, 2004) . In vivo and in vitro assays reveal the functions of some important signals directing coronary vessel formation, involving adhesion molecules, transcription factors and several growth factors Morabito et al., 2001; Olivey and Svensson, 2010) . These factors, which are important for epicardial EMT and further steps in coronary vessel formation, could inherently originate from the epicardium and EPDCs as well as from the myocardium (Olivey and Svensson, 2010) . Although some elements involved in EMT and subsequent steps in epicardial cell differentiation and migration have been identified, the mechanisms that drive the specific spatial and temporal pattern of coronary vasculogenesis are largely unknown.
It has been proposed that hypoxia triggers coronary vascular development. A range of cellular responses to hypoxia is mediated by hypoxia-inducible factors (HIFs), a heterodimer composed of a constitutively expressed HIFb subunit and an oxygen sensitive HIFa subunit (Wenger, 2002) . To date, three HIFa genes and over 100 HIF regulated genes have been identified (Wenger et al., 2005) . Components of the HIF complex have been described to be required for normal development and patterning of the cardiovascular system (Dunwoodie, 2009; Ramirez-Bergeron and Simon, 2001 ). Loss of hypoxia inducible factor-1a (HIF-1a) in the mouse severely disrupts myocardial and vascular endothelial development and embryos die around E10 (Iyer et al., 1998; Ryan et al., 1998) . It was also reported that the absence of HIF-1b (ARNT) in mice results in abnormal cardiac morphogenesis and embryonic lethality by E10 (Adelman et al., 2000; Maltepe et al., 1997) . Using the avian model, it was shown that environmental oxygen influences embryonic angiogenesis and hypoxia treatment causes myocardial and coronary artery anomalies and an increase of capillary density in hypoxic regions (Nanka et al., 2008) . Our previous studies utilizing the hypoxia marker EF5 [2-(2-nitro-1H-imidazol-1-yl)-N-(2,2,3,3,3 pentafluoropropyl)acetamide] revealed the atrioventricular junction (AVJ), ventricular apex, and interventricular septum (IVS) are relatively hypoxic in embryonic hearts. Many of these regions corresponded to the sites where major coronary vessels develop. Furthermore, hypoxia indicators and nuclear labeling of HIF-1a were co-localized in these hypoxic regions (Wikenheiser et al., 2006) . Altered HIF-1a expression levels in the myocardium disrupted normal patterning of coronary vessels, suggesting that differential levels of hypoxia within the embryonic myocardium modulate coronary vessel development through transcriptional regulation by HIF-1 (Wikenheiser et al., 2009, in press) .
Though the importance of myocardial HIF in regulating coronary vasculogenesis has long been accepted, the functions of epicardial-HIF during coronary vessel development have not been studied (Tomanek et al., 2003) . To unravel the in vivo roles of epicardial-HIF signaling, we disturbed HIF-1a gene expression and analyzed the consequences in ovo, in ex vivo explant culture, and also in various in vitro systems. Here, we present evidence that HIF-1 has a complex regulatory role during specific steps of epicardial development. While EMT was stimulated by the forced expression of constitutively active HIF-1a (caHIF1a), EPDCs transduced with caHIF1a displayed profoundly impaired invasion into and migration within the myocardium. Our findings support the potential for micro-environmental hypoxia via HIFs and the VEGF pathway to regulate both EMT and their ability to migrate within the myocardium.
Materials and methods

Chicken and quail fertilized eggs
Fertile White Leghorn chicken (Gallus gallus domesticus) eggs were obtained from Case Western Reserve University's Squire Valleevue Farm (Cleveland, OH, USA) or from Charles River (MA, USA). Fertile quail (Coturnix coturnix communis) eggs were purchased from (Boyd's Bird Company, Inc. Pullman, WA, USA). Eggs were incubated in a humidified forced draft hatching incubator (G.Q.F. Manufacturing Co., Savannah, GA, USA) at 38 1C to the appropriate stages. The embryos were staged according to the method of Hamburger and Hamilton (HH, Hamburger and Hamilton, 1951) .
In ovo injection of engineered adenoviruses into the pericardial space and assessment of EPDC migration Using a modification of a previously described method (Fisher et al., 1997; Fisher and Watanabe, 1996) , 0.5 ml adenovirus containing AdcaHIF1a or AdGFP (1 Â 10 9 pfu/ml) was injected into the pericardial space of the avian heart at stage HH 24 (ED 4), when the surface of the heart is largely covered by the epicardium. The AdcaHIF1a virus bears a constitutively active form of human HIF-1a (caHIF1a) and green fluorescent protein (GFP) sequence which were driven by a dual CMV promoter (Kelly et al., 2003) . The caHIF1a contains a deletion of the oxygendependent degradation domain (residues 392-520) and two missense mutations (Pro567Thr and Pro658Gln). AdGFP containing the CMV promoter that drives expression of GFP was used as a control. After injection, eggs were returned to the incubator and embryos were harvested at stage HH26 (ED 5) and HH28 . GFP positive cells located in different regions and positions were scored as follows. Comparable areas were randomly chosen from non-serial sections for each group. The number of positive cells containing distinct DAPI stained nuclei within these areas were counted for each sample. At least 10 areas were scored for each different region and the average number was determined by the total number of positive cells divided by the total number of areas counted in each of six independent experiments for each stage (HH26 and HH28). DAPI positive cells at the AVJ were also counted using the same method as described before.
Collagen gel assay and quantification of migration
The collagen gel assay was performed as previously described with some modifications (Dokic and Dettman, 2006) . Briefly, neutralized collagen I gel was added to 24 well plates (700 ml/well) and allowed to solidify at 37 1C in the incubator for 60 min. Stage HH25 (ED 4.5) avian hearts were harvested in sterile PBS and placed onto the surface of the gels which were covered by serum free M199 medium. After 24 h culturing at 37 1C, 5% CO 2 , hearts were removed and epicardial monolayers were allowed to grow out on the surface of the gel in serum free medium for 24 h. For virus infection experiments, monolayers were incubated overnight with serum free M199 containing AdGFP or AdcaHIF1a (1 Â 10 9 pfu/ml) and the medium was then replaced with M199 supplemented with 10% fetal bovine serum (FBS) or 10% FBSþ50 ng/ml VEGFA to trigger migration. After 36 h incubation, gels were fixed in 4% paraformaldehyde (PFA) in 1 Â PBS, washed and embedded in 1.5% agarose. Embedded samples were equilibrated in 30% sucrose (w/v) To evaluate cell migration, the Image J software (NIH) was used to measure the distance for each GFP positive (for adenovirus experiments) or DAPI stained (for inhibition experiments) cell that migrated from the surface into the gel. At least 15 comparable non-serial sections were chosen and analyzed for each group per independent experiment. For each treatment group, the average distance of migration was calculated by the total distance of cell migration divided by the total number of cells counted. Three independent experiments were performed for each treatment.
Organ culture assay
For ex ovo migration assays, stage HH25 (ED 4.5) avian hearts were excised from embryos in sterile PBS and cultured overnight at 37 1C in serum free M199 medium added adenovirus (AdGFP or AdcaHIF1a, 1Â 10 9 pfu/ml). Then hearts were placed in fresh M199 medium supplemented with 10% FBS and cultured for 
Cell culture and adenovirus infection
For primary avian epicardial cell culture, stage HH25 (ED 4.5) chicken or quail hearts were dissected and explanted into tissue culture-treated dishes with M199 medium containing 10% FBS. Hearts were removed after 24 h and the attached epicardial monolayers were allowed to grow in fresh medium. Immortalized cells derived from E13.5 mouse hearts (Obtained from Dr. Barnett, Vanderbilt University, USA) were propagated at 33 1C on collagen I coated dishes in DMEM supplemented with 10% FBS, insulintransferrin-selenium (Invitrogen) and 10 units/ml mouse IFNgamma (Peprotech, NJ, USA) (Austin et al., 2008 (Dokic and Dettman, 2006; Eid et al., 1992) . All cells were cultured at 37 1C in a 5% CO 2 culture incubator. Prior to infection, cells were washed with sterile PBS and then incubated with serum free medium containing adenovirus (AdGFP or AdcaHIF1a, 1 Â 10 9 pfu/ml) overnight at 37 1C. GFP expression in cells was monitored to determine the transfection efficiency. Virus infected primary quail epicardial cells were incubated with recombinant human TGFb1 (final concentration 250 pM, Peprotech) for 48 h to stimulate smooth muscle cell differentiation.
Immunohistochemistry
Dissected hearts or heart explants were fixed in fresh 4% PFA for 1 h at room temperature, then washed in 1 Â PBS and equilibrated in 30% sucrose overnight at 4 1C before embedding in OCT. 10 mm thick sections were collected on treated slides (Plus, Fisher) and immunostained with antibodies. For HIF-1a and VEGFA staining, primary antibody was detected with goat antirabbit IgG secondary antibody conjugated with biotin (Vector, Burlingame, CA) at 1:400 (HIF-1a) or 1: 100 (VEGFA) dilution, and the signal was amplified with the TSA systems with fluorescein tyramide signal (Perkin Elmer, Boston, MA) (HIF-1a) or DAB system (Vector) (VEGFA). VEGFA staining was quantified using Image J software. Cells were washed in PBS and fixed with 4% PFA for 10 min at room temperature, then washed in PBS and permeabilized with 0.2% Triton X-100 for 5 min. After blocking with 2% bovine serum albumin in PBS for 1 h, cells were incubated with diluted primary antibodies overnight at 4 1C and detected with appropriate secondary antibodies.
The following antibodies were used: anti-ZO1 antibody ( (1:40, Invitrogen) was used to label F-actin to delineate the cellular cytoskeleton. Terminal deoxynucleotidyltransferase (TdT) analysis (TUNEL) was carried out on frozen sections or fixed cells and developed with DAB according to the manufacturer's protocol (In situ cell death detection kit, Roche, IN, USA). Photomicrographs were captured with an inverted fluorescence microscope (Leica DM2500) and QCapture Pro software.
For quantification of cell numbers, comparable areas were randomly chosen from each group and numbers of positive cells were counted. At least 6 areas were scored for each sample.
Western blotting
Proteins were quantified using a Bradford assay (Pierce Biotech, IL, USA) and equal amounts were loaded onto 10% SDS-PAGE gels (Bio-Rad, CA, USA) and transferred to a PVDF membrane (Millipore, MA, USA). Membranes were blocked for 1 h at room temperature followed by incubation with primary antibodies overnight at 4 1C. The following antibodies were used: anti-b actin (1:10,0000, Sigma), anti-E-cadherin (1:1000, BD Biosciences, CA, USA), anti-HIF-1a (1:500, Novus, CO, USA). Then the blots were incubated with appropriate secondary anbibodies for 1 h at room temperature. Signals were then visualized with a HRP detection kit (Pierce).
Real time RT-PCR
Total RNA was isolated from cultured avian epicardial cells using the RNeasy mini kit (Qiagen, CA, USA) and 1 mg of total RNA was used for cDNA synthesis with the iscriptcDNA synthesis kit (Bio-Rad) according to the manufacturer's instructions. Real-time PCR was performed using SYBR (SYBR supermix, Bio-Rad). 18S was used as the internal control. The sequences of the primers were as follows:
Transwell experiments
Adenovirus infected primary quail epicardial cells were starved in serum free medium for 18 h and seeded at a density of 1 Â 10 4 cells/well onto the upper insert (non-coated) of the transwell chamber (Corning, MA, USA). The bottom chamber was filled with M199 medium (700 ml/well) supplemented with 10%
FBS or growth factors: VEGFA (15 ng/ml, Invitrogen) or TGFb1
(5 ng/ml) as the chemical attractant. Cells were permitted to migrate for 12 h. Then the non-migrated cells on the upper side were removed carefully with a cotton swab and the filters were fixed with 4% PFA before staining with DAPI solution. Migrated cells were counted in five randomly chosen fields under fluorescent microscope at 100 Â magnification. Three independent experiments were performed for each treatment.
Statistical analysis
Data are presented as means7SEM. All Statistical analysis was performed using student's paired t test. P valueo0.05 was considered significant.
Results
Expression of constitutively active HIF-1a in the epicardium inhibits EPDC migration into the myocardium During avian embryo development, the heart is largely covered by epicardial cells by stage HH24 (Hiruma and Hirakow, 1989) .
Endogenous HIF-1a expression in the epicardium and subepicardium from stage HH24 to stage HH28 was examined by immunofluorescence staining (Figs. 1, S7 ). Few ventricular epicardial or subepicardial cells were HIF-1a positive at stage HH24 to stage HH28 (Fig. 1A -D and M-P). Most of the HIF-1a positive staining in the epicardium or subepicardium was concentrated at the atrioventricular junction (AVJ) at these stages (Fig. 1E-L) . Besides the staining in the epicardium and subepicardium, an increase of the number of HIF1a positive nuclei in the myocardium was also observed during stages 26-28 ( Fig. 1E-P) . In order to investigate the intrinsic role of epicardial HIF-1 during EMT and subsequent EPDC migration in vivo, we utilized a replication defective adenovirus carrying a mutated form of HIF-1a that eliminates key regulatory oxygen-sensitive sites inhibiting protein turnover and rendering it constitutively active (caHIF1a) (Kelly et al., 2003) . We injected the caHIF1a co-expressing a GFP reporter gene or the gene for GFP alone (negative control) into the pericardial space of avian embryos at stage HH24. This injection strategy ensured that the epicardium, but not the underlying myocardium was infected. We were able to determine whether the gain of function of HIF-1a (caHIF1a) had an effect on EPDC migration by comparing the location in histological sections of AdcaHIF1a-and the AdGFP-infected cells; both sets of infected cells expressed the GFP tag. We observed that avian hearts transduced with AdcaHIF1a had reduced numbers of cells expressing the GFP marker within the myocardium (Fig. 2) . In quails this defect was first identified at stage HH26 ( Fig. 2A and B) , and became more obvious at later stages ( Fig. 2C and D) . A similar deficiency of GFPþ cell numbers in the myocardium was also detected in another avian species, chicken embryos, injected with caHIF1a ( Fig. 2E and F) . GFPþ cells were quantified in comparable areas within the myocardium of AdcaHIF1a-and AdGFP-infected quail embryos at various developmental stages. We discovered that the most significant decrease in the number of EPDCs infected with AdcaHIF1a occurred in the ventricular myocardium (Po0.01, Fig. 2G ). This reduction was less prominent in the atrial myocardium than in the myocardium of the ventricle and at the AVJ (Fig. 2G) .
We further performed an ex vivo assay to examine whether we can observe similar defects in this more accessible system where the viral infection was more consistent. Quail hearts were dissected and infected with adenovirus in vitro, then processed for immunohistochemistry. The results confirmed that AdcaHIF1a greatly inhibited the migration of EPDCs into the myocardium in this ex vivo environment (Fig. 3A, B and D) . Furthermore, we observed similar inhibition of EPDC migration in cultured hearts treated with desferrioxamine (DFO), a hypoxia-mimetic agent that induces HIF-1a protein (Fig. 3C and D) . This defect was also reproduced in AdcaHIF1a infected chicken embryo heart explants cultures (data not shown).
To test the intrinsic biological effects of caHIF1a epicardial cells devoid of influences from other types of cells which exist in ovo, in vitro 3-dimensional collagen gel assays were performed. Epicardial monolayers derived from stage HH25 quail hearts were cultured on collagen gels and infected with adenovirus. GFP was used to track epicardial cell invasion into the matrix. GFPþ cells from AdGFP-infected control cultures were found to penetrate deep into the gel (Fig. 3E) . In contrast, GFP þ cells from AdcaHIF1a infected cultures failed to infiltrate the collagen gel (Fig. 3F) . Importantly, we observed that uninfected GFP-cells detected by DAPI staining were able to migrate extensively even in the presence of AdcaHIF1a infected cells (arrowheads, Fig. 3F ), indicating that the inhibition was cell autonomous. Measurements of the distances traveled by GFPþ EPDCs in the collagen gels demonstrated a statistically significant decrease (about 60%, 35.475.6 mm for AdGFP-infected cells and 16.475.5 mm for AdcaHIF1a control) in the invasion of AdcaHIF1a infected cells (Po0.01, Fig. 2G ). Furthermore, monolayers treated with DFO also exhibited impaired invasion of epicardial cells with cell migration distances significantly decreased by 50% (Po0.05, Fig. 3H-J) . Western blot of mouse epicardial cell lysates indicated that AdcaHIF1a infection and the DFO are effective methods mimicking the hypoxic condition by inducing the accumulation of HIF-1a protein (Fig. 3K) . These ex ovo and in vitro data closely mirrored our in ovo experiments and strongly indicate that over-expression of stable HIF-1a in the epicardium impairs the ability of epicardial-derived cells to travel a distance into matrices in a complex active or inactive myocardium or in a simple collagen gel.
Forced expression of HIF-1a does not affect cell proliferation and survival but stimulates epithelial-mesenchymal transformation
There are many potential explanations for fewer AdcaHIF1a infected cells in the myocardium compared to AdGFP cells. AdcaHIF1a infected cells (1) cannot proliferate or survive before they migrate, (2) are unable to migrate at all, (3) are not capable of undergoing EMT, (4) fail to respond to extrinsic signals, and/or (5) may undergo EMT and travel within the epicardial matrix but are incapable of migrating to and/or within the myocardium.
The total number of cells in the epicardium and subepicardium at the AVJ was evaluated by DAPI staining and no obvious difference was detected between the control and AdcaHIF1a group, suggesting that cell proliferation and survival are not influenced by AdcaHIF1a infection (Fig. 4A) . To further determine whether the reduction in number of AdcaHIF1aGFPþ cells within the myocardium resulted from reduced cell proliferation of epicardial cells or EPDCs, quail heart sections were stained with an anti-phosphohistone H3 (PH-3), a sensitive marker for mitosis. There was no significant difference in the number of PH-3 positive cells in the epicardium infected with either AdGFP or AdcaHIF1a (Figs. S1A, E and I). Likewise, the data showed no significant difference in TUNEL þ immunostained apoptotic cell numbers between the AdGFP and AdcaHIF1a infected hearts (Figs. S1B, F and I). Furthermore, in vitro cultured quail epicardial cells displayed no alteration of proliferation or survival in AdcaHIF1a transfected cells (Figs. S1C, D , G, H and J). According to these results, changes in cell proliferation and survival could not explain the reduced numbers of HIF-1a transduced EPDCs within the myocardium.
Based on our immunostaining data, EPDC movement into the connective tissue of the subepicardium was grossly normal despite the fact that their migration into and within the myocardium was inhibited. In both AdcaHIF1a and control AdGFPinfected quail hearts, GFPþ cells were detected populating the width of the subepicardial space of the AVJ region even where the epicardium is especially thick (maximal thickness is around 75 mm, Fig. 4B, C ). There were no significant differences in the number of EPDCs in the subepicardium of the AVJ between the control AdGFP and the AdcaHIF1a transduced hearts (Fig. 4D) . While evaluation of GFP þ cell migration within the subepicardium covering the ventricle and atrium was difficult due to the thinner epicardium than at the AVJ, no discernable gross differences were observed. To examine the intrinsic motility of AdcaHIF1a cells, we utilized a Transwell assay thus eliminating matrix invasion requirements and exclusively assayed their response to growth factor stimuli. Infected primary cultures of quail epicardial cells were seeded onto the un-coated top chambers and exposed for 12 h to the medium in the lower wells containing FBS, vascular endothelial growth factor A (VEGFA, 15 ng/ml) or transforming growth factor beta-1 (TGF-b1, 5 ng/ml) (Han et al., 2012; Kim et al., 2006) . Cells that migrated through the pores of the filter to the underside were microscopically quantified. There was no significant difference in the number of migrated cells in the AdGFP and AdcaHIF1a cultures, suggesting that the expression of caHIF1a had no influence on the initial chemotactic responses of the epicardial cell, that is, their ability to release and migrate a limited distance in the direction of the source of the growth factors (Fig. 4E) .
As epicardial precursors contribute to the coronary vasculature, EPDCs need to undergo EMT to acquire the ability to migrate. Unchanged EPDC invasion into and within the subepicardium and responses to growth factor stimuli directed us to postulate that epicardial EMT was not disrupted due to the expression of caHIF1a. To test this hypothesis, quail epicardial monolayers from stage HH25 hearts were cultured and transfected with AdGFP and AdcaHIF1a. Since loss of cell-cell adhesion is an important early step in epicardial EMT, we stained the cells with an antibody to zonula occludens-1 (ZO-1), a marker for tight junctions that directly interact with the actin cytoskeleton. Primary epicardial cells infected with AdcaHIF1a lost strong immunostaining for ZO-1 at cell-cell borders when compared to the AdGFP-infected cells (Figs. 5A-F) . This feature was replicated in chicken epicardial cell cultures (data not shown). Moreover, we detected a decreased expression of ZO-1 and elongation of cell shape in immortalized mouse embryonic epicardial cells infected with AdcaHIF1a (Figs. S2A-F) . Phalloidin staining further indicated that stress fibers were increased in cells with forced expression of caHIF1a when compared to controls (Figs. S2G-L) . In the rat adult epicardial cell culture system, we further observed an even distribution of b-catenin at cell membranes at cell-cell junctions in AdGFP-infected control cells (Fig. S3A-C) , whereas robust staining was detected in the cytoplasm in cells expressing caHIF1a (Fig. S3D-F) . These findings suggest that forced expression of caHIF1a results in the altered expression and distribution of proteins important in cell-cell connections, a characteristic of cells undergoing EMT.
Previous studies supported that EMT is accompanied by enhanced expression of twist and a decrease of E-cadherin, while integrin a4 is reported to be an inhibitor of EMT (Dettman et al., 2003; Lee et al., 2006) . We further examined the transcript levels of some important EMT markers in primary chicken epicardial monolayer cultures by quantitative real-time PCR. In AdcaHIF1a infected cells, there were statistically significant changes in the expression levels of a subset of EMT markers including the increased expression of twist2 and reduced levels of integrin a4 and b1 transcripts, as compared to the AdGFP controls (Fig. 5G) . No significant changes were observed in the expression of twist1 and vimentin. Furthermore, E-cadherin protein levels were decreased in rat adult epicardial cells transfected with AdcaHIF1a (Fig. S3G) . The alteration of the tested EMT markers is consistent with the loss of epithelial characteristics detected from immunostaining experiments, indicating that expression of caHIF1a in epicardial cells promotes EMT. Therefore because EMT itself is not inhibited but in fact enhanced, the defective invasion/migration of HIF-1a transduced epicardial cells may be due to changes that inhibit cells from migrating substantial distances into and interacting with substrates after they undergo EMT.
Differentiation of EPDCs into smooth muscle cells was not affected in cells infected with AdcaHIF1a
Another point to consider while investigating the role of HIF-1 in regulating the commitment of EPDC to coronary vasculogenesis is the differentiation of the EPDC into diverse cell types. We utilized an in vitro culture system to address whether EPDCs with caHIF1a can give rise to vascular smooth muscle cells (VSMCs). It has been shown that TGFb1 triggers epicardial EMT and the differentiation of epicardial cells into VSMCs (Austin et al., 2008; Olivey et al., 2006) . Here, quail monolayers were treated with TGFb1 for 48 h and then analyzed for differentiation into VSMCs by staining with two different markers: anti-smooth muscle actin (SMA) and SM22a. Expression of SMA or SM22a was observed in both AdGFP and AdcaHIF1a infected cells in response to TGFb1 (Figs. 6A-F, S4A-F) , suggesting that forced expression of caHIF1a did not disrupt the differentiation of EPDCs into VSMCs. Quantification further confirmed no significant difference between AdGFP and AdcaHIF1a groups in terms of the percent of SMAþ GFPþ cells (Figs. 6G and S4G ). In summary, caHIF1a expression in epicardial cells had no effect on EPDC differentiation into vascular smooth muscle cells.
The up-regulation of Flt-1 in epicardial cells expressing constitutively active HIF-1a contributes to their altered migration Many of the pathways that are involved in epicardial EMT and in directing EPDC migration and differentiation are activated by growth factors, including VEGF (Olivey and Svensson, 2010) . VEGFA and vascular endothelial growth factor receptor 1 (VEGFR1, Flt-1) are known HIF-1 target genes (Forsythe et al., 1996; Gerber et al., 1997; Wenger et al., 2005) . We used quantitative real time RT-PCR to examine the expression levels of VEGF and VEGF receptors in primary cultures of chicken epicardial cells with caHIF1a expression. We found that cells infected with AdcaHIF1a expressed 3.7 fold more Flt-1 transcript levels than those infected with the control AdGFP (Fig. 7A) . By contrast, transcript levels of Flk-1 did not increase significantly (Fig. 7A) . VegfA expression was also up-regulated, although modestly (1.5-fold, P o 0.05) (Fig. 7A) . Immunohistochemical analysis further confirmed that VEGFA protein levels were not markedly increased nor were patterns of expression changed by AdcaHIF1a (Fig. S5A-C) . Primary cultures of quail epicardial cells demonstrated the same expression pattern for these transcripts as the chicken epicardial cells (Fig. S5D) . Given that Flk-1 mediates most of the responses to VEGF and the soluble form of Flt-1 acts as a decoy receptor that sequesters VEGF from Flk-1 (Shibuya, 2006) , the above data imply that the up-regulation of Flt-1 is a possible underlying mechanism associated with the aberrant EPDC migration within the myocardium. On this basis, we proposed that the increased expression of Flt-1 induced by AdcaHIF1a negatively regulated the VEGF intracellular signaling mediated by Flk-1, which resulted in the impaired invasion of EPDCs into and within the myocardium.
To test our hypothesis, we used the collagen gel assay to examine the in vitro migration of EPDCs in the presence of inhibitors for the VEGF signaling pathway. Chicken epicardial cells were cultured in 10% FBS medium with or without VEGF signaling pathway inhibitors. FBS significantly stimulated epicardial cell invasion into collagen gels in the DMSO vehicle control (Fig. 7B) . In contrast, when monolayers were treated with a specific intrinsic inhibitor (SU5416) of Flk-1 tyrosine kinase activity, the migration of cells was strongly reduced (Fig. 7C) . The average distance traveled from the surface by cells treated with SU5416 was 35% that of the DMSO control group (Fig. 7L) . The recombinant soluble Fc-sFlt1 chimera was utilized to block extrinsic VEGF signaling by trapping VEGF and further preventing its binding and activation of cellular receptors (Ambati et al., 2006; Roberts et al., 2004) . We observed that addition of Fc-sFlt1 inhibited the EPDC invasion stimulated by FBS (Fig. 7E and F) . Although the effect was not as robust as with SU5416, the migration distance was significantly diminished (by 40%) (Fig. 7L) . MAZ51, an inhibitor specific for VEGFR3 when used at low concentration had no impact on the cell invasion triggered by FBS (Fig. 7B and D) , suggesting that the inhibition was specifically taking effect through signaling pathways mediated by VEGF:Flk-1/Flt-1. To replicate our experiments in an organ model, the ex vivo whole heart explant culture system was used to test the effect of VEGF inhibitors on EPDC migration in the myocardium. The results demonstrated that SU5416 (Fig. 7H) and Fc-sFlt1 (Fig. 7K) treatment blocked the EPDC invasion into the myocardium when compared to DMSO (Fig. 7G) and BSA (Fig. 7J) control groups. Moreover, we again did not identify any inhibition of migration in the MAZ51-treated hearts (Fig. 7I) . The collagen gel system was further used to examine whether VEGFA can rescue the inhibition of cell invasion. Evaluation of the migration distance clearly indicated that the average migration distance significantly increased in VEGFA treated AdcaHIF1aGFPþ cells compared to the AdcaHIF1a control cells (Figs. 7M, S6 ). Together these data support the hypothesis that enhanced expression of Flt-1 in EPDCs as a result of expressing caHIF1a inhibited cell invasion into and within the myocardium via the inhibition of the VEGF pathway.
Discussion
HIF regulates EPDC invasion
Although previous studies provide some clues about the regulatory system that drives EPDC invasion, the mechanisms that spatio-temporally regulate EPDC migration to their final destination have not been defined. In this study, we present evidence that HIF-1 regulates EPDC invasion and hypoxia is a potential guiding signal required for proper coronary vessel formation (Fig. 8) . Our immunostaining data and previous studies support that during heart development, differential levels of hypoxia exist in specific regions thereby establishing a dynamic process for moderating the levels of HIF-1a expression in the epicardium and myocardium that coordinate the transcriptional regulation of multiple target genes essential for proper cardiac development, including EPDCs' proficiency to form coronary vessels. At the stages we investigated, HIF-1a expression in the epicardium and subepicardium is always high at the AVJ but lower on the ventricle. However, its expression in the myocardium increases during heart development. Indeed, a current hypothesis is that the local hypoxic microenvironment influences the maintenance and differentiation of both embryonic and adult stem cells (Mohyeldin et al., 2010; Simon and Keith, 2008) . We postulate that by affecting the normal dynamic expression of HIF-1 protein in AdcaHIF1a infected embryonic epicardium, the inability to moderate the temporal-spatial expression of HIF-1 exacerbates intrinsic signals that promote the proper migration of EPDCs (Fig. 8) . Fig. 8 . Model of how hypoxia regulates EPDC invasion into the ventricular myocardium. In AdGFP-injected controls, HIF-1a is expressed in some epicardial cells at an early stage (stage HH24) and its expression in the myocardium increases at later stages (i.e., stage HH28). This pattern guides EPDC invasion through the subepicardium and myocardium. However, disruption of the normal pattern of HIF expression with a sustained expression in the epicardium mediated by adenovirus caHIF1a results in the up-regulation of expression of Flt-1 (possibly for both membrane and soluble forms), which leads to the inhibition of EPDC migration into the myocardium.
The major coronary vessels form with predictable patterns in species with four-chambered hearts. However, coronary anomalies associated with negative consequences for morbidity and mortality do occur (Frommelt and Frommelt, 2004; Jureidini et al., 1998; von Ludinghausen, 2003) . The underlying mechanisms for coronary anomalies arising during cardiogenesis have not been understood. Here, we indicate that HIF-1 is crucial for regulating epicardial EMT and also regulates the invasion of the progenitor cells of vessels into the myocardium. Very hypoxic sulcus regions, as detected by hypoxia indicators and nuclearlocalized HIF1a, are also the regions where major coronary vessels develop (Mancini et al., 1991; Nanka et al., 2006; Wikenheiser et al., 2009) . Such major coronary vessels are generally found within the epicardium at sulcus regions but in rare conditions, such as myocardial bridging, a segment of a major coronary vessel can dive into the myocardium (Loukas et al., 2011) . Our findings provide a potential explanation for why the major coronary vessels usually stay within the epicardium. The sulcus regions in the embryonic heart would have more HIF-1 positive epicardial cells than other regions. Thus these cells would undergo EMT more readily and be inhibited from migrating into the myocardium. This would result in a dense population of precursor cells within the epicardium at sulcus regions that would be available for differentiation and incorporation into large vessels. In other epicardial regions of the heart, EMT would occur later but without the high levels of HIF-1 in epicardial cells, the precursors would be able to travel substantial distances into the myocardium. In this scenario, the level of epicardial HIF would control the location of large, medium and small vessels within the myocardial wall by controlling the depth reached by progenitor cells.
The VEGF signaling pathway and EPDC migration in the myocardium
Our findings support that caHIF1a inhibits EPDC invasion through the disruption of the VEGF signaling pathway. VEGF binds to tyrosine kinase receptors and plays a major role in vasculogenesis and angiogenesis (Shibuya, 2006) . It has been recognized that expression of some crucial components of the VEGF pathway are regulated by hypoxia (Elvert et al., 2003; Forsythe et al., 1996; Gerber et al., 1997; Han et al., 2010) . Investigating the relationship between hypoxia, VEGF, and the development of coronary vasculature reveals that vascular growth is accelerated in heart explants incubated under hypoxic conditions, accompanied by the up-regulation of VegfA mRNA (Yue and Tomanek, 1999) . In ovo injection of VEGF-Trap or soluble VEGFRs precludes or reduces the formation of coronary arteries (Tomanek et al., 2006) . In addition, in vitro treatment with VEGF 164 increases epicardial EMT whereas blocking the VEGF signaling pathway via Flk-1 specific inhibitor decreases endothelial tube formation (Nesbitt et al., 2009) . These published studies further support a critical correlation among HIF, VEGF and coronary vasculogenesis.
Our data document that forced expression of caHIF1a in epicardial cells increased the expression of Flt-1 transcripts. Although some controversy exists, Flk-1 and Flt-1 are considered positive and negative regulators of VEGF signaling, respectively (Shibuya, 2006) . While membrane bound Flt-1 possesses higher affinity for VEGFA than Flk-1, it has relatively weak tyrosine kinase activity (De Vries et al., 1992) . In its soluble form, sFlt1, competes with Flk-1 by binding to VEGFA and can be considered to be of great importance in generating a VEGF gradient. Indeed, levels of VEGF signaling are well documented in controlling sprouting of endothelial cells (Chappell et al., 2009; Han et al., 2010; Kappas et al., 2008) . In our study, blocking VEGF signaling using either cell intrinsic or extrinsic inhibitors resulted in inhibition of EPDC migration similar to that observed when epicardial cells were transduced with caHIF1a. These results indicate that VEGF signaling is required for EPDC movement within the myocardium and caHIF1a inhibits this process by elevating the levels of Flt-1.
Distinct roles of VEGF signaling during valve development have been described in a transgenic mouse study indicating that Flt-1 is required for endocardial cell EMT in the outflow tract (OFT) while Flk-1 plays a role in morphogenesis of atrioventricular canal (AVC) cushions (Stankunas et al., 2010) . Another significant finding in human fetal hearts shows that endothelial cells lining epicardial coronary arteries exclusively express Flt-1 but those lining myocardial capillaries express both Flt-1 and Flk-1 (Partanen et al., 1999) . While Flt-1 have been shown to be HIF-1a and HIF-2a transcriptional targets, Flk-1 is considered to be only a HIF-2 target (Elvert et al., 2003; Kappel et al., 1999) . Considering these data, we propose HIF-1 and HIF-2 may have distinct roles in regulating the spatiotemporal levels of Flt-1 and Flk-1 and the intrinsic Flt-1:Flk-1 ratio strongly influences the final location of EPDCs and their derivatives within the depth of the heart wall.
Although myocardially expressed VEGF has been recognized to potently stimulate epicardial EMT and further induce coronary vessel formation by a paracrine process (Tomanek et al., 2006) , we believe this to be the first report supporting that cell autonomous VEGF signaling is involved in regulating EPDC invasion of the myocardium. It is valuable to further unravel the downstream factors associated with the VEGF pathway whose function is indispensable for proper EPDC migration into the myocardium.
